Press Releases :: IceCure Medical Ltd. (ICCM)

Skip to main content Skip to section navigation Skip to footer

Oct 02, 2023 8:00 am EDT

Independent Study Validates IceCure's ProSense Cryoablation is Safe & Effective Outpatient Procedure for Breast Cancer with 96.8% Success Rate

Sep 22, 2023 8:00 am EDT

Renowned Spanish Radiologist Lucía Graña-López to Present Data Using IceCure Medical's ProSense at European Society of Breast Imaging Scientific Meeting 2023

Sep 20, 2023 7:00 am EDT

IceCure Medical Receives FDA Response to De Novo Classification Request for Breast Cancer

Sep 08, 2023 8:00 am EDT

IceCure Medical to Join Hands-On Cryoablation Session with ProSense and Host Symposium Led by Renowned Doctors at the CIRCE 2023 Annual Congress

Sep 05, 2023 8:00 am EDT

IceCure Medical's ProSense Cryoablation System Receives Regulatory Approval in Brazil

Aug 28, 2023 8:00 am EDT

IceCure Medical Takes Next Major Initiative as it Prepares to Accelerate the Commercialization of ProSense in U.S. and Canada: Appoints VP of Sales, North America

Aug 21, 2023 8:00 am EDT

IceCure Medical Continues to Experience Growing Global Interest in ProSense: Featured at the 16th Thai Breast Symposium

Aug 14, 2023 8:00 am EDT

IceCure Medical Reports First Half 2023 Financial & Operational Results: Global Adoption of Cryoablation Technology Gaining Momentum

Aug 07, 2023 8:00 am EDT

IceCure Medical to Report Second Quarter 2023 Financial & Operational Results on August 14, 2023

Jul 24, 2023 8:00 am EDT

Health Canada Approves IceCure Medical's Minimally Invasive ProSense Cryoablation System

Select a page:

rss_feed News RSS

IceCure Medical HQ: 7 Ha’Eshel St., PO Box 3163, Caesarea, 3079504, Israel

© 2023 All Rights Reserved IceCure Medical

Branding by

Terms of Use | Privacy | Last Updated: April 9, 2023